Virtus Investment Advisers, Inc. Veracyte, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $119 Million
- Q4 2024
A detailed history of Virtus Investment Advisers, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 40,689 shares of VCYT stock, worth $1.36 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
40,689
Previous 55,798
27.08%
Holding current value
$1.36 Million
Previous $1.9 Million
15.12%
% of portfolio
1.36%
Previous 1.59%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
337Shares Held
80.2MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$261 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$221 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$141 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$137 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.39B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...